Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Asian Pacific Journal of Cancer Prevention

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 27356714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between the interleukin-6 gene polymorphisms and renal cancer risk.

  2015cited by this paper
• Role of interleukin-6 gene polymorphisms in the development of prostate cancer.

  2015cited by this paper
• The Global Burden of Cancer 2013.

  2015cited by this paper
• Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women

  2015influential reference
• Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population

  2014influential reference
• Interleukin-6 genotypes and serum levels in Chinese Hui population.

  2014cited by this paper
• Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer.

  2013cited by this paper
• Interleukin 6 Promoter Polymorphisms in Normal Han Chinese Population

  2011cited by this paper
• Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.

  2010cited by this paper
• Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer.

  2010cited by this paper
• Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.

  2009influential reference
• Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers

  2009cited by this paper
• Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.

  2009cited by this paper
• Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women

  2009influential reference
• IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States

  2007cited by this paper
• The emerging roles of forkhead box (Fox) proteins in cancer

  2007influential reference
• Interleukin 6 G−174 C polymorphism and breast cancer risk

  2006cited by this paper
• Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.

  2005cited by this paper
• Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women

  2005cited by this paper
• The IL-6 -174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans.

  2004cited by this paper
• Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas

  2004cited by this paper
• Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.

  2003cited by this paper
• -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.

  2003cited by this paper
• Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.

  2003cited by this paper
• The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism.

  2002cited by this paper
• Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein.

  2002cited by this paper
• Interleukin-6 Gene −174G>C and −572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery

  2001cited by this paper
• Interleukin-6 (IL-6) and the Prognosis of Abdominal Aortic Aneurysms

  2001cited by this paper
• The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

  2001cited by this paper
• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

  1998cited by this paper
• Steroid receptors in breast cancer

  1991cited by this paper

• The linkage between IL‐6 rs1800797 variant and breast cancer susceptibility in Bangladeshi women: A case‐control study

  2024cites this paper
• Analysis of Interleukin-6 Gene Variants (rs1800795, rs1800796, rs1554606, rs1800797, rs2069840, rs12700386, and rs2069861) as Prognostic Markers in Breast Cancer: A Systematic Review, Meta-Analysis, and Network Analysis

  2023cites this paper
• Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk

  2021cites this paper
• The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer

  2021cites this paper
• The −174G>C and −596G>A Polymorphisms Are Not Associated with Circulating IL-6 Levels in Breast Cancer Patients from Jalisco, México

  2020cites this paper
• Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study

  2019cites this paper
• Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls.

  2018cites this paper
• The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer.

  2018cites this paper
• Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.

  2018cites this paper